The deal, which is expected to close in 2025’s third quarter, will set up Tanabe Pharma as an independent company poised to benefit from Bain’s financial ... it was a very clear target for ...

As media companies compete with giant tech players to buy "more evergreen IP" that can be used across platforms, it brings up ...

At this time, I would like to welcome everyone to the SelectQuote's fiscal second quarter 2025 earnings call. All lines have ...

Wells Fargo analyst Finian O’Shea maintained a Buy rating on Bain Capital Specialty Finance (BCSF – Research Report) today and set a price target of $18.00. The company’s shares closed yeste ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes and cancer with “precision medicine”. Leverage the power of TipRanks ...

A person familiar with the transaction said the investment would value Dhoot Transmission at over $1 billion and that Bain was acquiring a significant minority stake in the company. A spokesperson ...

Bain’s return, a month after it put the 178-year-old company in play and a week since it ran into a rival suitor, sets up Insignia as 2025’s first private equity shootout at an ASX-listed company.

TOKYO/HONG KONG (Reuters) -Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, in a ...

TOKYO -- U.S. investment fund Bain Capital will acquire Japanese aircraft interior maker Jamco for a total of around 100 billion yen ($634 million), including its debt, in another move by the ...

Nikkei reported on Monday the company is likely to sell its Tanabe Mitsubishi Pharma unit to Bain Capital for more than 500 billion yen ($3.2 billion). Mitsubishi Chemical said in a statement on ...

Last week, U.S.-based investment manager CC Capital Partners offered to buy Insignia for A$2.87 billion, days after the Australian company rejected Bain Capital's initial takeover bid, citing it ...

McKinsey & Company, Bain & Company, and Boston Consulting Group — collectively referred to as MBB — are widely considered the top three strategy consulting firms in the world. Sometimes ...